Management of Euglycemic Diabetic Ketoacidosis

被引：0
|
作者：
Mathew, Daniya S. [1 ]
Ng, Kimberly E. [2 ]
Jacob, Elsen C. [2 ]
机构：
[1] St Johns Univ, Coll Pharm & Hlth Sci, New York, NY 11439 USA
[2] St Johns Univ, Coll Pharm & Hlth Sci, Dept Clin Hlth Profess, New York, NY USA
来源：
US PHARMACIST | 2021年 / 46卷 / 11期
关键词：
INHIBITORS;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Euglycemic diabetic ketoacidosis (EDKA) is a rare, acute, life-threatening emergency that is characterized by euglycemia, metabolic acidosis, and ketoacidosis. Unlike DKA, the diagnosis of EDKA is often overlooked because of the absence of hyperglycemia. The mechanism behind EDKA involves a general state of starvation that results in ketosis while normoglycemia is maintained. EDKA may be associated with precipitating factors, including sodium-glucose cotransporter 2 inhibitors, starvation, pregnancy, alcohol use, surgery, and drug-induced intoxication. A stepwise approach is used in the management of EDKA. Pharmacists can assist the medical team in preventing EDKA and can play a role in the management of EDKA.
引用
收藏
页码：HS1 / HS6
页数：6
相关论文
共 50 条
  • [31] Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus A case report
    Lee, In Hee
    Ahn, Dong Jik
    MEDICINE, 2020, 99 (21)
  • [32] Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis Presenting With Severe Abdominal Pain Mimicking Acute Peritonitis
    Wang, Qianwen
    Wu, Kangze
    Luo, Xiaoqian
    Dong, Xin
    Liu, Weifeng
    Tang, Zhe
    Zhang, Bo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [33] Acidosis without marked hyperglycemia. Euglycemic diabetic ketoacidosis associated with SGLT2-Inhibitors
    Valek, R.
    Von der Mark, J.
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2017, 112 (02) : 145 - 148
  • [34] Report Euglycemic Diabetic Ketoacidosis After Cardiac Surgery in a Patient Treated With Empagliflozin for Type 2 Diabetes Mellitus
    Wohlrab, Peter
    Kainz, Matthias
    Schiferer, Arno
    Zapletal, Bernhard
    Tschernko, Edda
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (07) : 2066 - 2069
  • [35] Sodium-Glucose Cotransporter 2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: The Other Side of the Coin!
    Kamath, Sangita D.
    Kumar, Umesh
    Shrivastava, Vikki
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [36] EVALUATION AND MANAGEMENT OF THE CRITICALLY ILL ADULT WITH DIABETIC KETOACIDOSIS
    Long, Brit
    Willis, George C.
    Lentz, Skyler
    Koyfman, Alex
    Gottlieb, Michael
    JOURNAL OF EMERGENCY MEDICINE, 2020, 59 (03): : 371 - 383
  • [37] Late-Onset Euglycemic Diabetic Ketoacidosis in a Patient With Massive Stroke Requiring Decompressive Craniectomy: A Case Report
    Hussaini, Syed Ahmed
    Aziz, Afia
    Musa, Muzamil
    Alamin, Mohammed
    Danjuma, Mohammed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [38] Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient Who Underwent Surgery for Pancreatic Carcinoma: A Case Report
    Luo, Xiaoqian
    Ji, Ran
    Lu, Weina
    Zhu, Hong
    Li, Libin
    Hu, Jun
    FRONTIERS IN SURGERY, 2022, 9
  • [39] Euglycemic diabetic ketoacidosis: A rare but serious side effect of sodium-glucose co-transporter 2 inhibitors
    Lakusic, Nenad
    Merkas, Ivana Sopek
    Sliskovic, Ana Marija
    Cerovec, Dora
    WORLD JOURNAL OF CARDIOLOGY, 2022, 14 (10): : 561 - 564
  • [40] Sodium glucose cotransporter-2 inhibitors induced euglycemic diabetic ketoacidosis: Two case reports and a review of the literature
    Bitar, Zouheir Ibrahim
    Maadarani, Ossama Sajeh
    Alabdali, Fawaz
    Teama, Ahmed
    Elsawah, Walid
    Mohsen, Mohammed Jaber
    Elzoueiry, Mahmoud Mostafa
    CLINICAL CASE REPORTS, 2022, 10 (02):
12345